Polyglutamine Proteins at the Pathogenic Threshold Display Neuron-specific Aggregation in a Pan-neuronal Caenorhabditis Elegans Model

Overview

Journal J Neurosci

Specialty Neurology

Date 2006 Jul 21

PMID 16855087

Citations 116

Authors

Heather R Brignull

Finola E Moore

Stephanie J Tang

Richard I Morimoto

Affiliations

Soon will be listed here.

Abstract

The basis of neuron-specific pathogenesis, resulting from the expression of misfolded proteins, is poorly understood and of central importance to an understanding of the cell-type specificity of neurodegenerative disease. In this study, we developed a new model for neuron-specific polyQ pathogenesis in Caenorhabditis elegans by pan-neuronal expression that exhibits polyQ length-dependent aggregation, neurotoxicity, and a pathogenic threshold at a length of 35-40 glutamines. Analysis of specific neurons in C. elegans revealed that only at the threshold length, but not at shorter or longer lengths, polyQ proteins can exist in a soluble state in certain lateral neurons or in an aggregated state in motor neurons of the same animal. These results provide direct experimental evidence that the expression of a single species of a toxic misfolded protein can exhibit a range of neuronal consequences.

Citing Articles

A nucleolar mechanism suppresses organismal proteostasis by modulating TGFβ/ERK signalling.

Zhu H, Bruck-Haimson R, Zaretsky A, Cohen I, Falk R, Achache H Nat Cell Biol. 2025; 27(1):87-102.

PMID: 39753948 DOI: 10.1038/s41556-024-01564-y.

TMEM106B C-terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans.

Riordan R, Saxton A, Han M, McMillan P, Kow R, Liachko N Alzheimers Dement. 2024; 21(2):e14468.

PMID: 39711302 PMC: 11848199. DOI: 10.1002/alz.14468.

Docosahexaenoic Acid (DHA) Supplementation in a Triglyceride Form Prevents from Polyglutamine-Induced Dysfunctions in .

Mora I, Teixido A, Vazquez-Manrique R, Puiggros F, Arola L Int J Mol Sci. 2024; 25(23).

PMID: 39684306 PMC: 11640917. DOI: 10.3390/ijms252312594.

Olfactory dysfunction as an early pathogenic indicator in models of Alzheimer's and polyglutamine diseases.

Xue W, Lei Z, Liu B, Guo H, Yan W, Jin Y Front Aging Neurosci. 2024; 16:1462238.

PMID: 39411283 PMC: 11473296. DOI: 10.3389/fnagi.2024.1462238.

Hetero-oligomerization of TDP-43 carboxy-terminal fragments with cellular proteins contributes to proteotoxicity.

Kitamura A, Fujimoto A, Kawashima R, Lyu Y, Sasaki K, Hamada Y Commun Biol. 2024; 7(1):743.

PMID: 38902525 PMC: 11190292. DOI: 10.1038/s42003-024-06410-3.

References

Morley J, Brignull H, Weyers J, Morimoto R . The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2002; 99(16):10417-22. PMC: 124929. DOI: 10.1073/pnas.152161099. View

Miyawaki A . Visualization of the spatial and temporal dynamics of intracellular signaling. Dev Cell. 2003; 4(3):295-305. DOI: 10.1016/s1534-5807(03)00060-1. View

Zoghbi H, Orr H . Glutamine repeats and neurodegeneration. Annu Rev Neurosci. 2000; 23:217-47. DOI: 10.1146/annurev.neuro.23.1.217. View

Andachi Y, Tsalik E, Pilgrim D, Kohara Y, Hobert O . A regulatory cascade of three homeobox genes, ceh-10, ttx-3 and ceh-23, controls cell fate specification of a defined interneuron class in C. elegans. Development. 2001; 128(11):1951-69. DOI: 10.1242/dev.128.11.1951. View

Margolis R, Ross C . Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases. Trends Mol Med. 2001; 7(11):479-82. DOI: 10.1016/s1471-4914(01)02179-7. View

Brownlee D, Fairweather I . Exploring the neurotransmitter labyrinth in nematodes. Trends Neurosci. 1999; 22(1):16-24. DOI: 10.1016/s0166-2236(98)01281-8. View

Perutz M . Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem Sci. 1999; 24(2):58-63. DOI: 10.1016/s0968-0004(98)01350-4. View

Shulman J, Shulman L, Weiner W, Feany M . From fruit fly to bedside: translating lessons from Drosophila models of neurodegenerative disease. Curr Opin Neurol. 2003; 16(4):443-9. DOI: 10.1097/01.wco.0000084220.82329.60. View

Phair R, Misteli T . High mobility of proteins in the mammalian cell nucleus. Nature. 2000; 404(6778):604-9. DOI: 10.1038/35007077. View

10.

Kim S, Nollen E, Kitagawa K, Bindokas V, Morimoto R . Polyglutamine protein aggregates are dynamic. Nat Cell Biol. 2002; 4(10):826-31. DOI: 10.1038/ncb863. View

11.

Ross C . When more is less: pathogenesis of glutamine repeat neurodegenerative diseases. Neuron. 1995; 15(3):493-6. DOI: 10.1016/0896-6273(95)90138-8. View

12.

Tonkiss J, Calderwood S . Regulation of heat shock gene transcription in neuronal cells. Int J Hyperthermia. 2005; 21(5):433-44. DOI: 10.1080/02656730500165514. View

13.

Faber P, Alter J, Macdonald M, Hart A . Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc Natl Acad Sci U S A. 1999; 96(1):179-84. PMC: 15113. DOI: 10.1073/pnas.96.1.179. View

14.

Berney C, Danuser G . FRET or no FRET: a quantitative comparison. Biophys J. 2003; 84(6):3992-4010. PMC: 1302980. DOI: 10.1016/S0006-3495(03)75126-1. View

15.

Rankin C . From gene to identified neuron to behaviour in Caenorhabditis elegans. Nat Rev Genet. 2002; 3(8):622-30. DOI: 10.1038/nrg864. View

16.

Poirier M, Jiang H, Ross C . A structure-based analysis of huntingtin mutant polyglutamine aggregation and toxicity: evidence for a compact beta-sheet structure. Hum Mol Genet. 2005; 14(6):765-74. DOI: 10.1093/hmg/ddi071. View

17.

Satyal S, Schmidt E, Kitagawa K, Sondheimer N, Lindquist S, Kramer J . Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc Natl Acad Sci U S A. 2000; 97(11):5750-5. PMC: 18505. DOI: 10.1073/pnas.100107297. View

18.

Orr H . Beyond the Qs in the polyglutamine diseases. Genes Dev. 2001; 15(8):925-32. DOI: 10.1101/gad.888401. View

19.

Scherzinger E, Sittler A, Schweiger K, Heiser V, Lurz R, Hasenbank R . Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: implications for Huntington's disease pathology. Proc Natl Acad Sci U S A. 1999; 96(8):4604-9. PMC: 16379. DOI: 10.1073/pnas.96.8.4604. View

20.

Gusella J, Macdonald M . Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci. 2001; 1(2):109-15. DOI: 10.1038/35039051. View